Interleukins 2 and 12 activate natural killer cytolytic responses of peripheral blood mononuclear cells from patients with head and neck squamous cell carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 122, Issue 5, 1996, Pages 541-547

  Rashleigh, Stephen P ^a,b   Kusher, David I ^a,c   Endicott, James N ^a   Rossi, Anne R ^a,c   Djeu, Julie Y ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Univ of S Florida Sch of Medicine ^*

^c JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOMODULATION; MONONUCLEAR CELL; NATURAL KILLER CELL; SQUAMOUS CELL CARCINOMA;

EID: 0029886565     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.1996.01890170073014     Document Type: Article

References (27)

1. Schantz SP, Ordonez NG. Quantitation ol natural killer cell function and risk of metastatic poorly differentiated head and neck cancer. Nat Immun. 1991;10: 278-288.
2. Mickel RA, Kessler DJ, Taylor JMG, Lichtenstein A. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients Cancer Res. 1988;48.5017-5022
3. Gonzalez FM, Vargas JA, Lacoma F, et al. Natural killer cell activity in laryngeal carcinoma Arch Otolaryngol Head Neck Surg. 1993;119:69-72.
4. Schantz SP, Shillitoe EJ, Campbell B. Natural killer cell activity and head and neck cancer, a clinical assessment J Natl Cancer Inst 1986,77:869-875.
5. Kumazawa H, Hess M Influence of serum derived from patients with head and neck cancer on natural killer cell activity. Oncology. 1991;48:372-376
6. Clayman GL, Young G, Taylor DL, Savage HE, Lavedan P, Schantz SP. Detection of regulatory factors of lymphokine-activated killer cell activity in head and neck cancer patients treated with interleukin-2 and Interferon alpha. Ann Otol Rhinol Laryngol 1992;101:909-915.
7. Stern AS, Podlaski FJ, Hulmes JD, et al Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA. 1990;87:6808-6812.
8. Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF) a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989;170.827-845.
9. Wolf SF, Temple PA, Kobayashi M, et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991;146.3074-3081
10. Gately MK, Wolitzky AG, Quinn PM, Chizzonite R. Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol. 1992;143.127-142.
11. Lieberman MD, Sigal RK, Williams NN, Daly JM. Natural killer cell stimulatory factor (NKSF) augments natural killer cell and antibody-dependent tumoricidal response against colon carcinoma cell lines. J Surg Res 1991;50:410-415
12. + NK cells J Immunol. 1992;148:2429-2436
13. Gately MK, Desai BB, Wolitzky AG, et al. Regulation of human lymphocytic proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 1991;147:874-882.
14. Robertson MJ, Soiffer RJ, Wolf SF, et al. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF). cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med. 1992;175: 779-788
15. Chan SH, Perussia B, Gupta JW, et al. Induction of Interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med. 1991;173:869-879.
16. Chizzonite R, Truitt T, Desai BB, et al. IL-12 receptor, I: characterization of the receptor on phytohemaglutinin-activated human lymphoblasts. J Immunol. 1992, 148:3117-3124.
17. Desai BB, Quinn PM, Wolitzky AG, Mongini PK, Chizzonite R, Gately MK IL-12 receptor, II: distribution and regulation of receptor expression. J Immunol. 1992; 148:3125-3132
18. 1. J Immunol. 1988;141:4067-4073
19. Blartchard DK, Hall RE, Djeu JY. Role of CD18 in lymphokine activated killer (LAK) cell-mediated lysis of human monocytes: comparison with other LAK targets. Int J Cancer. 1990,45:312-319
20. Press HF, Baines MG, Rubin P, Shragae P, Patterson MS. Spontaneous human lymphocyte mediated cytotoxicity against tumor target cells, IX: the quantitation of natural killer activity J Clin Immunol. 1981;1:51-63.
21. Tripp CS, Wolf SF, Unanue ER. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A 1993;90:3725-3729
22. Naume B, Gately MK, Desai BB, Sundan A, Espevik T. Synergistic effects of interleukin 4 and interleukin 12 on NK cell proliferation. Cytokine 1993;5:35-46.
23. Soitfer RJ, Robertson MJ, Murray C, Cochran K, Ritz J. Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies. Blood 1993;82:2790-2796
24. Rossi AR, Pericle F, Rashleigh S, Janiec J, Djeu JY Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12 Blood. 1994;83:1323-1328.
25. Chien C. Interleukin-2 Immunotherapy in children. Pediatrics 1990;86.937-943.
26. Lee, RA. Cardiorespiratory effects of immunotherapy with interleukin-2 J Clin Oncol. 1989;7:7-20.
27. Brunda MJ, Luistro L, Warner RR, et al. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med. 1993;178:1223-1230.